The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Targeted RNA Sequencing-Global Market Insights and Sales Trends 2025
Synopsis
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
The global Targeted RNA Sequencing market size is expected to reach US$ 7570 million by 2029, growing at a CAGR of 22.5% from 2023 to 2029. The market is mainly driven by the significant applications of Targeted RNA Sequencing in various end use industries. The expanding demands from the Research Institutes, Hospitals & Clinics, Biotechnology Company and Diagnostic Lab, are propelling Targeted RNA Sequencing market. Exome Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enrichment Sequencing segment is estimated at % CAGR for the next seven-year period.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted RNA Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted RNA Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted RNA Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted RNA Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted RNA Sequencing covered in this report include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen and GENEWIZ, etc.
The global Targeted RNA Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Global Targeted RNA Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted RNA Sequencing market, Segment by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Global Targeted RNA Sequencing market, by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted RNA Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
The global Targeted RNA Sequencing market size is expected to reach US$ 7570 million by 2029, growing at a CAGR of 22.5% from 2023 to 2029. The market is mainly driven by the significant applications of Targeted RNA Sequencing in various end use industries. The expanding demands from the Research Institutes, Hospitals & Clinics, Biotechnology Company and Diagnostic Lab, are propelling Targeted RNA Sequencing market. Exome Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enrichment Sequencing segment is estimated at % CAGR for the next seven-year period.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted RNA Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted RNA Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted RNA Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted RNA Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted RNA Sequencing covered in this report include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen and GENEWIZ, etc.
The global Targeted RNA Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Global Targeted RNA Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted RNA Sequencing market, Segment by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Global Targeted RNA Sequencing market, by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted RNA Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Targeted RNA Sequencing
1.1 Targeted RNA Sequencing Market Overview
1.1.1 Targeted RNA Sequencing Product Scope
1.1.2 Targeted RNA Sequencing Market Status and Outlook
1.2 Global Targeted RNA Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Targeted RNA Sequencing Market Size by Region (2018-2029)
1.4 Global Targeted RNA Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Targeted RNA Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Targeted RNA Sequencing Market Size (2018-2029)
1.6.1 North America Targeted RNA Sequencing Market Size (2018-2029)
1.6.2 Europe Targeted RNA Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Targeted RNA Sequencing Market Size (2018-2029)
1.6.4 Latin America Targeted RNA Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Targeted RNA Sequencing Market Size (2018-2029)
2 Targeted RNA Sequencing Market by Type
2.1 Introduction
2.1.1 Exome Sequencing
2.1.2 Enrichment Sequencing
2.1.3 Amplicon Sequencing
2.2 Global Targeted RNA Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Targeted RNA Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Targeted RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Targeted RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Targeted RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Targeted RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Targeted RNA Sequencing Revenue Breakdown by Type (2018-2029)
3 Targeted RNA Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Research Institutes
3.1.2 Hospitals & Clinics
3.1.3 Biotechnology Company
3.1.4 Diagnostic Lab
3.2 Global Targeted RNA Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Targeted RNA Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Targeted RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Targeted RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Targeted RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Targeted RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Targeted RNA Sequencing Revenue Breakdown by Application (2018-2029)
4 Targeted RNA Sequencing Competition Analysis by Players
4.1 Global Targeted RNA Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2022)
4.3 Date of Key Players Enter into Targeted RNA Sequencing Market
4.4 Global Top Players Targeted RNA Sequencing Headquarters and Area Served
4.5 Key Players Targeted RNA Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted RNA Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Targeted RNA Sequencing Products, Services and Solutions
5.1.4 Thermo Fisher Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Illumina
5.2.1 Illumina Profile
5.2.2 Illumina Main Business
5.2.3 Illumina Targeted RNA Sequencing Products, Services and Solutions
5.2.4 Illumina Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 Illumina Recent Developments
5.3 Roche Holdings
5.3.1 Roche Holdings Profile
5.3.2 Roche Holdings Main Business
5.3.3 Roche Holdings Targeted RNA Sequencing Products, Services and Solutions
5.3.4 Roche Holdings Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 BGI Recent Developments
5.4 BGI
5.4.1 BGI Profile
5.4.2 BGI Main Business
5.4.3 BGI Targeted RNA Sequencing Products, Services and Solutions
5.4.4 BGI Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 BGI Recent Developments
5.5 Eurofins
5.5.1 Eurofins Profile
5.5.2 Eurofins Main Business
5.5.3 Eurofins Targeted RNA Sequencing Products, Services and Solutions
5.5.4 Eurofins Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Recent Developments
5.6 LabCorp
5.6.1 LabCorp Profile
5.6.2 LabCorp Main Business
5.6.3 LabCorp Targeted RNA Sequencing Products, Services and Solutions
5.6.4 LabCorp Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 LabCorp Recent Developments
5.7 Berry Genomics
5.7.1 Berry Genomics Profile
5.7.2 Berry Genomics Main Business
5.7.3 Berry Genomics Targeted RNA Sequencing Products, Services and Solutions
5.7.4 Berry Genomics Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Berry Genomics Recent Developments
5.8 Macrogen
5.8.1 Macrogen Profile
5.8.2 Macrogen Main Business
5.8.3 Macrogen Targeted RNA Sequencing Products, Services and Solutions
5.8.4 Macrogen Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Macrogen Recent Developments
5.9 GENEWIZ
5.9.1 GENEWIZ Profile
5.9.2 GENEWIZ Main Business
5.9.3 GENEWIZ Targeted RNA Sequencing Products, Services and Solutions
5.9.4 GENEWIZ Targeted RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 GENEWIZ Recent Developments
6 North America
6.1 North America Targeted RNA Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Targeted RNA Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted RNA Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted RNA Sequencing Market Dynamics
11.1 Targeted RNA Sequencing Industry Trends
11.2 Targeted RNA Sequencing Market Drivers
11.3 Targeted RNA Sequencing Market Challenges
11.4 Targeted RNA Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
